New hope to keep cancer at bay for patients with double health challenge
NCT ID NCT04661943
Summary
This study tested whether a drug called chidamide could help prevent cancer from coming back in patients who have both a type of lymphoma and hepatitis B. It involved 30 adults whose lymphoma had completely disappeared after initial chemotherapy. The goal was to see if taking chidamide as a long-term maintenance treatment could extend the time patients remain cancer-free and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.